Rheumatic Manifestations and Diseases From Immune Checkpoint Inhibitors in Cancer Immunotherapy

Immune checkpoint inhibitors (ICIs), which can enhance antitumor immunity and inhibit cancer growth, have revolutionized the treatment of multiple cancers and dramatically decreased mortality. However, treatment with ICIs is directly associated with immune-related adverse events (irAEs) because of i...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Pan, Deng, Xuan, Hu, Zhishuo, Chen, Zhe, Huang, Yao, Wang, Ke, Qin, Kai, Huang, Ying, Ba, Xin, Yan, Jiahui, Han, Liang, Tu, Shenghao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599930/
https://www.ncbi.nlm.nih.gov/pubmed/34805229
http://dx.doi.org/10.3389/fmed.2021.762247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599930/
https://www.ncbi.nlm.nih.gov/pubmed/34805229
http://dx.doi.org/10.3389/fmed.2021.762247

Ejemplares similares